Diabetic Macular Edema (DME) Recruiting Phase 3 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04063358Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract SurgeryTreatment